Two-Headed PROTAC: An Effective New Tool for Targeted Protein Degradation

被引：43
|
作者：
Cyrus, Kedra [1 ]
Wehenkel, Marie [1 ]
Choi, Eun-Young [2 ]
Swanson, Hollie [2 ]
Kim, Kyung-Bo [1 ]
机构：
[1] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA
来源：
CHEMBIOCHEM | 2010年 / 11卷 / 11期
关键词：
estrogen receptor; ligases; PROTAC; proteomics; ubiquitin-proteasome pathway; ARYL-HYDROCARBON RECEPTOR; CHIMERIC MOLECULES; CHEMICAL GENETICS; UBIQUITINATION; BINDING; SCF;
D O I：
10.1002/cbic.201000222
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Better than one: A novel class of PROTAC that recruits target protein for ubiquitination and subsequent degradation by the proteasome has been successfully synthesized and tested for its activity to degrade a target protein. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码：1531 / 1534
页数：4
相关论文
共 50 条
  • [21] PROTAC-mediated protein degradation: New therapeutic modality
    Burslem, George
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [22] G4-PROTAC: targeted degradation of a G-quadruplex binding protein
    Patil, Kiran M.
    Chin, Danielle
    Seah, Hui Ling
    Shi, Qi
    Lim, Kah Wai
    Anh Tuan Phan
    CHEMICAL COMMUNICATIONS, 2021, 57 (95) : 12816 - 12819
  • [23] Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation
    Sun, Donghuan
    Zhang, Jing
    Dong, Guoqiang
    He, Shipeng
    Sheng, Chunquan
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14276 - 14288
  • [24] ClickRNA-PROTAC for Tumor-Selective Protein Degradation and Targeted Cancer Therapy
    Teng, Xucong
    Zhao, Xuan
    Dai, Yicong
    Zhang, Xiangdong
    Zhang, Qiushuang
    Wu, Yuncong
    Hu, Difei
    Li, Jinghong
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2024, 146 (40) : 27382 - 27391
  • [25] A new path to targeted protein degradation?
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (10) : 706 - 707
  • [26] Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway
    Kim, Hanbyeol
    Park, Jeongbae
    Kim, Jeong-Mok
    BIOMEDICINES, 2022, 10 (09)
  • [27] PROTAC'ING CENTROSOME AMPLIFICATION PROTEINS: TARGETED PROTEIN DEGRADATION AS A NOVEL THERAPEUTIC STRATEGY IN GLIOBLASTOMA
    Thomaz, Amanda
    Fielding, Andrew
    NEURO-ONCOLOGY, 2024, 26
  • [28] A new path to targeted protein degradation?
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 706 - 707
  • [29] Augmenting Protein Degradation Capacity of PROTAC through Energy Metabolism Regulation and Targeted Drug Delivery
    Tan, Mixiao
    Li, Xiaoyang
    Cheng, Long
    Long, Xianli
    Cao, Guoliang
    Yu, Shengji
    Ran, Haitao
    Feng, Helin
    Wang, Hai
    ADVANCED MATERIALS, 2025, 37 (01)
  • [30] Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein
    Bhardwaj, Vijay Kumar
    Purohit, Rituraj
    APPLIED MATERIALS TODAY, 2024, 38
12345